Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
  1. 4 Planned sale President and CEO sold 22,463 shares at an average $6.07 ($136,366)
  2. 4 Planned sale Chief Financial Officer sold 77,920 shares at an average $6.15 ($478,849)
  3. 4 Planned sale Chief Medical Officer sold 121,117 shares at $5.47 ($662,510)
  4. 4 Open-market sale 10% owner sold 40,000 shares at $5.25 ($210,000)
  5. 4 Planned sale President and CEO sold 1,867 shares at $6.03 ($11,252)
  6. 4 Planned sale Chief Financial Officer sold 5,291 shares at an average $6.03 ($31,884)
  7. 4 Planned sale President and CEO sold 200 shares at $6.00 ($1,200)
  8. 4 Planned sale Chief Financial Officer sold 600 shares at $6.00 ($3,600)
  9. 4 Planned sale President and CEO sold 15,720 shares at an average $6.07 ($95,342)
  10. 4 Planned sale Chief Financial Officer sold 32,439 shares at an average $6.06 ($196,676)
  11. 4 Open-market sale 10% owner sold 50,000 shares at an average $4.94 ($246,800)
  12. 5 Insider Annual Insider Trading Report
  13. 4 Planned sale Chief Financial Officer sold 8,706 shares at $6.44 ($56,054)
  14. 4 Planned sale President and CEO sold 14,000 shares at $6.36 ($89,048)
  15. 4 Open-market buy Director bought 1,000 shares at $2.93 ($2,925)
  16. 4 Open-market buy Director bought 5,000 shares at $2.90 ($14,495)
  17. 4 Option exercise 10% owner acquired 323,125 shares (option exercise)
  18. 5 Insider Annual Insider Trading Report
  19. 4 Grant or award President and CEO acquired 56,420 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 3 of 39 · 776 filings